Abstract Library

#4217 Prediction of recurrence for grade 1-2 small bowel neuroendocrine neoplasms after curative-intended resection

Introduction: In patients with grade 1 to 2 small bowel neuroendocrine neoplasms (SB-NEN) reccurrence rates are reported up to 50%. No prediction tools exist yet to identify patients at high-risk for recurrence in SB-NENs.

Conference:

Presenting Author:

Authors: Erdmann F, Addeo P, Falconi M, Hennings J, Makay �,

Keywords: small bowel neuroendocrine neoplasm, recurrence, nomogram,

#3970 Unveiling racial disparities in hepatic neuroendocrine tumors: A comprehensive analysis

Introduction: Investigating the impact of race on the clinicopathologic features and prognosis of hepatic neuroendocrine tumors is a complex and important area of research. Notably, there are significant differences in the clinical presentation, pathologic features, and prognosis of hepatic neuroendocrine tumors across racial groups.

Conference:

Presenting Author:

Authors: Han D, Zhang Z, Du H,

Keywords: Ethnicity, Prognosis, Neuroendocrine tumor, Independent prognostic factor,

#3772 R-ache-L score – A nomogram model for predicting prognosis of lung neuroendocrine tumors according to primary tumor side

Introduction: The prognosis of atypical carcinoids (AC) is worse than that of typical carcinoids (TC). Molecular analyses have suggested a more heterogeneous disease for the first ones. However, no previous study has established an individualized predictive model for the prognosis of lung neuroendocrine tumos (Lu-NETs) considering the location of the primary tumor in the right versus left lung parenchyma.

Conference:

Presenting Author: La Salvia A

Authors: La Salvia A, Marcozzi B, Manai C, Mazzilli R, Pallocca M,

Keywords: Lung neuroendocrine tumor, Tumor location (left vs right parenchyma), Prognostic factor, Nomogram, R-ache-L Prognostic Score,

#3524 Correlation of loss of ATRX expression with scintigraphic imaging studies in pancreatic neuroendocrine neoplasms

Introduction: Somatic inactivating mutations of ATRX (α thalassemia/mental retardation syndrome X-linked) in pancreatic neoplasms (pNENs) are associated with aggressive phenotype and are considered an independent prognostic factor of poor overall survival.

Conference:

Presenting Author:

Authors: Tsoli M, Kyriakopoulos G, Daskalakis K, Chatziioannou S, Alevroudis E,

Keywords: ATRX, somatostatin receptor scintigraphy, FDG-PET/CT,

#3337 Somatostatin analogues in the treatment of enteropancreatic neuroendocrine tumors

Introduction: Enteropancreatic neuroendocrine tumors are rare neoplasms.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Correa R

Authors: Sanchez Dominguez G, Jiménez J, Sanchez J, Correa R, Alegria J,

Keywords: enteropancreatic neuroendocrine tumor,